Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term her-2. Found 9 abstracts

Chu CS, Boyer J, Schullery DS, Gimotty PA, Gamerman V, Bender J, Levine BL, Coukos G, Rubin SC, Morgan MA, Vonderheide RH, June CH. Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission. Cancer Immunology Immunotherapy. 2012 May;61(5):629-41.
Hayashi N, Nakamura S, Tokuda Y, Yagata H, Yoshida A, Ota H, Hortobagyi GN, Cristofanilli M, Ueno NT. Serum HER2 levels determined by two methods in patients with metastatic breast cancer. International Journal of Clinical Oncology. 2012 Feb;17(1):55-62.   PMCID: *
Ramaswamy B, Fiskus W, Cohen B, Pellegrino C, Hershman DL, Chuang E, Luu T, Somlo G, Goetz M, Swaby R, Shapiro CL, Stearns V, Christos P, Espinoza-Delgado I, Bhalla K, Sparano JA. Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo. Breast Cancer Research and Treatment. 2012 Apr;132(3):1063-72.   PMCID: *
Osipo C, Meeke K, Liu H, Cheng D, Lim S, Weichel A, Jordan VC. Trastuzumab therapy for tamoxifen-stimulated endometrial cancer. Cancer Research. 2005 Sep 15;65(18):8504-13.
Steffen AC, Wikman M, Tolmachev V, Adams GP, Nilsson FY, Stahl S, Carlsson J. In vitro characterization of a bivalent anti-HER-2 affibody with potential for radionuclide-based diagnostics. Cancer Biotherapy and Radiopharmaceuticals. 2005 Jun;20(3):239-48.
Lynch HT, Casey MJ, Lynch J, White TE, Godwin AK. Genetics and ovarian carcinoma. Seminars in Oncology. 1998 Jun;25(3):265-80.
Adams GP, McCartney JE, Wolf EJ, Eisenberg J, Huston JS, Bookman MA, Moldofsky P, Stafford WF, Houston LL, Weiner LM. Enhanced Tumor Specificity of 741f8-1(Sfv')(2), an Anti-C-Erbb- 2 Single-Chain Fv Dimer, Mediated by Stable Radioiodine Conjugation. Journal of Nuclear Medicine. 1995 Dec;36(12):2276-81.
Testa JR, Getts LA, Salazar H, Liu ZM, Handel LM, Godwin AK, Hamilton TC. Spontaneous Transformation of Rat Ovarian Surface Epithelial- Cells Results in Well to Poorly Differentiated Tumors with a Parallel Range of Cytogenetic Complexity. Cancer Research. 1994 May 15;54(10):2778-84.
Sauter ER, Keller SM, Erner S, Goldberg M. Her-2/Neu - a Differentiation Marker in Adenocarcinoma of the Esophagus. Cancer letters. 1993 Nov 30;75(1):41-4.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term her-2

her-2 neu expression protein survival neu oncogene breast-cancer carcinoma amplification overexpression Metastasis progression-free survival tumor localization trial internalization histone deacetylase inhibitors dna-adducts human-breast-cancer c-erbb-2 protein overexpression carcinomas c-erbb-2 oncogene activation human-breast monoclonal-antibodies c-ErbB-2 affibody-HER-2-iodine-radionuclide-SKBR-3-tumor Serum HER2 nonpolyposis colorectal-cancer tumor penetration oncogene amplification clinical utility cells proto- estrogen-receptor modulation sp1 phosphorylation binding esophageal adenocarcinoma egf receptor postmenopausal women p-iodobenzoate receptor susceptibility gene myc protooncogene Breast neoplasm chromosome-aberrations transcriptional athymic mice Dendritic cell Ovarian cancer-Vaccine-Clinical trial-Consolidation therapy regulatory t-cells extracellular domain antibody fragment gene-transcription sites proteins cancer gene oncoprotein erbb-2 immunotherapy tumor suppressor gene oncogenes peptide trastuzumab-based therapy single-chain fv tyrosine kinases heat-shock-protein-90 Trastuzumab p53 gene tumor-associated antigen immune-response HER2 neu oncoprotein heterozygosity Paclitaxel Metastatic breast cancer-Bevacizumab-Vorinostat-HDAC inhibitors oral-contraceptive use familial breast c- tumor single-chain fv molecules tumor growth surgical adjuvant breast suberoylanilide hydroxamic acid differentiation marker radioiodination kinase pathway lymphocytes ashkenazi-jewish individuals neu expression dna
Last updated on Wednesday, February 05, 2020